NovaBay Expands Global Ophthalmology Study of Pink Eye to India
[at noodls] – Phase 2b BAYnovation Study for the Treatment of Viral Conjunctivitis Includes 60 Clinical Sites Worldwide EMERYVILLE, CA – January 3, 2013 – NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology … more
View todays social media effects on NBY
View the latest stocks trending across Twitter. Click to view dashboard